Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Novartis » Page 3

Novartis

ADVERTISEMENT
In Depth

What Happened to the Plans for a Smart Contact Lens for Diabetics?

Originally projected to be on the market by 2020, excitement about the contact lens to measure glucose…

By External Contributor
January 25, 2018 - 5 minutes
News and Trends

Novartis Takes Genmab’s Leukemia Drug Off the Market

Genmab's leukemia drug will be available around the world through compassionate use programs, while it will…

By Alex Dale
January 22, 2018 - 3 minutes
Best in Biotech

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

Now that we've got the bad news out of the way, we're here to spread…

By Alex Dale
December 18, 2017 - 9 minutes
News and Trends

The FDA Approves the First CAR-T Cell Therapy for Cancer

The FDA has approved Novartis' CAR-T therapy Kymriah, opening the way for a new generation…

By Clara Rodríguez Fernández
August 31, 2017 - 3 minutes
News and Trends

Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks

European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’…

By Clara Rodríguez Fernández
August 29, 2017 - 2 minutes
News and Trends

Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns

Editor's Note: Novartis did note a death from cerebral hemorrhage in its hearing with the…

By Evelyn Warner
July 11, 2017 - 3 minutes
News and Trends

Novartis Scores Major Phase III Win with New Cardiovascular Drug

Novartis just announced that its anti-inflammatory drug, canakinumab, was able to clear a 10,000-plus patient Phase III…

By Melanie De Almeida
June 22, 2017 - 2 minutes
News and Trends

Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials

Bayer's and Regeneron's blockbuster Eylea could be facing serious competition, as Novartis boasts with positive…

By Melanie De Almeida
June 20, 2017 - 2 minutes
News and Trends

Novartis Announces New Data for its Psoriasis Blockbuster Cosentyx

Novartis has announced positive post-marketing results for its blockbuster Cosentyx, with which the pharma wants…

By Clara Rodríguez Fernández
June 15, 2017 - 1 minute
News and Trends

UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech

The UK-based VC Medicxi has raised a massive $300M (€268M) fund backed by Novartis and…

By Melanie De Almeida
June 15, 2017 - 3 minutes
News and Trends

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

Belgian Celyad is giving Novartis access to its IP for the production of allogeneic CAR-T…

By Melanie De Almeida
May 2, 2017 - 2 minutes
News and Trends

Novartis Negotiates its Way into the US Migraine Market

Amgen and Novartis have expanded their collaboration for the co-development of their migraine drug, ensuring…

By Melanie De Almeida
April 25, 2017 - 2 minutes
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days